Allen Anderson, MD
Advanced Heart Failure and Transplant Cardiology · San Antonio, TXNPI 1083775811
Payments from drug & device makers
Across 422 payments — averaging $1456.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$161K
- Pfizer$138K
- Merck$79K
- Boehringer Ingelheim$65K
- E.r. Squibb & Sons, L.L.C.$42K
- Bayer$39K
- plus $92K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 26 | $160,981 |
| Pfizer(2 entities) | 126 | $138,210 |
| Merck | 67 | $78,518 |
| Boehringer Ingelheim | 47 | $64,616 |
| E.r. Squibb & Sons, L.L.C. | 10 | $41,564 |
| Bayer | 26 | $38,605 |
| Bridgebio Pharma, Inc. | 18 | $23,650 |
| Lilly USA, LLC | 17 | $21,214 |
| Novartis | 13 | $14,326 |
| Edwards Lifesciences | 16 | $11,937 |
| GE HealthCare | 2 | $10,400 |
| Vifor Pharma, Inc. | 6 | $6,618 |
| Abiomed | 8 | $963 |
| GSK | 8 | $912 |
| Cvrx, Inc. | 4 | $434 |
| Alnylam Pharmaceuticals Inc. | 14 | $418 |
| Impulse Dynamics (USA) Inc. | 2 | $298 |
| Medtronic | 2 | $225 |
| AstraZeneca | 2 | $168 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $117 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $103 |
| Biotronik Inc. | 1 | $87 |
| Scpharmaceuticals Inc. | 1 | $38 |
| ZOLL Circulation Inc | 1 | $30 |
| Johnson & Johnson | 1 | $27 |
| Amgen | 1 | $20 |
How this compares
$614,604 in reported general payments places this provider in the 85th percentile of 75 advanced heart failure and transplant cardiology providers in Texas.
See all advanced heart failure and transplant cardiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in San Antonio
- Alejandro Folch SandovalSan Antonio$44K
- Rashonda CarlisleSan Antonio$30K
- Sachin GuptaSan Antonio$25K
- Mahek ShahSan Antonio$11K
- Tamer AmerSan Antonio$11K
- Mohammed AslamSan Antonio$8K
- Mahi AshwathSan Antonio$4K
- Robert GottliebDallas$14.1M
- Martin BerkDallas$1.9M
- Kunjan BhattAustin$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.